BioXcel Therapeutics (BTAI) PT Lowered to $66 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts BTAI Hot Sheet
Price: $0.90 +8.43%
Rating Summary:
7 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 33 | Down: 45 | New: 4
Rating Summary:
7 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 33 | Down: 45 | New: 4
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on BioXcel Therapeutics (NASDAQ: BTAI) to $66.00 (from $79.00) while maintaining a Buy rating.
You May Also Be Interested In
- Zillow Group (ZG) PT Lowered to $50 at DA Davidson
- Cognex (CGNX) PT Raised to $84 at Cantor Fitzgerald
- Douglas Emmett Inc. (DEI) PT Raised to $13 at Cantor Fitzgerald
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
